Evidence map›Paper›PMID 21140254›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2011

A three-dimensional cell biology model of human hepatocellular carcinoma in vitro.

Jianhua Tang, Jiefeng Cui, Rongxin Chen, Kun Guo, Xiaonan Kang, Yan Li, Dongmei Gao, Lu Sun, Changde Xu, Jie Chen and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Engineering cancer microenvironments forMaterials today (Kidlington, England) · 2015
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Jianhua TangLiver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, 136 Xue Yuan Road, Shanghai 200032, People's Republic of China.
Jiefeng Cui
Rongxin Chen
Kun Guo
Xiaonan Kang
Yan Li
Dongmei Gao
Lu Sun
Changde Xu
Jie Chen
Zhaoyou Tang
Yinkun Liu
Fudan University · CNMinistry of Education · ETFudan University Shanghai Cancer Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We established an in vitro 3-D model of metastatic hepatocellular carcinoma (HCC) by culturing MHCC97H cells on molecular scaffolds within a rotating wall vessel bioreactor. Morphological and biochemical analyses revealed that the 3-D HCC model mirrored many clinical pathological features of HCC in vivo, including cancer cell morphology, tissue ultrastructure, protein production and secretion, glucose metabolism, tissue-specific gene expression, and apoptosis. Xenografts into livers of nude mice resulted in tumorigenesis and distant metastasis. This 3-D HCC spheroid is a promising model for HCC tumor biology, anticancer drug screening, and for the establishment of HCC animal models.

Indexed as

Albuminsalpha-FetoproteinsAnimalsApoptosisCarcinoma, HepatocellularCell CycleCell Line, Tumorgamma-GlutamyltransferaseGene Expression ProfilingGlucoseHumansLiver NeoplasmsL-Lactate DehydrogenaseMaleMiceMice, Inbred BALB CAlbuminsalpha-Fetoproteinsgamma-GlutamyltransferaseGlucoseL-Lactate Dehydrogenase

Identifiers

PMID21140254
OpenAlexW1995874183

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.